Literature DB >> 18796274

Anxiety disorders and migraine intractability and progression.

Todd A Smitherman1, Donald B Penzien, Morris Maizels.   

Abstract

Comorbid psychopathology has been implicated as a risk factor for the chronification and progression of migraine. Although past research has focused principally on depression and migraine, recent research consistently has confirmed that a disproportionate number of migraineurs suffer from one or more comorbid anxiety disorders. Moreover, this research has implicated anxiety disorders as factors potentially associated with migraine intractability and progression; growing evidence suggests that anxiety disorders may be even more prognostically significant than depression. This article summarizes these recent developments, considers mechanisms underlying this comorbidity, discusses strategies for assessing and managing comorbid anxiety, and notes directions for future clinical and empiric work.

Entities:  

Mesh:

Year:  2008        PMID: 18796274     DOI: 10.1007/s11916-008-0039-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  44 in total

1.  Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs.

Authors:  F Radat; D Sakh; G Lutz; M el Amrani; M Ferreri; M G Bousser
Journal:  Headache       Date:  1999 Jul-Aug       Impact factor: 5.887

Review 2.  Risk factors for headache chronification.

Authors:  Ann I Scher; Lynn A Midgette; Richard B Lipton
Journal:  Headache       Date:  2008-01       Impact factor: 5.887

3.  Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management.

Authors:  Michel Lantéri-Minet; Françoise Radat; Marie-Hélène Chautard; Christian Lucas
Journal:  Pain       Date:  2005-11-14       Impact factor: 6.961

4.  Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes.

Authors:  K D Juang; S J Wang; J L Fuh; S R Lu; T P Su
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Headache types and panic disorder: directionality and specificity.

Authors:  N Breslau; L R Schultz; W F Stewart; R Lipton; K M Welch
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

8.  Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.

Authors:  Soon-Tae Lee; Jong-Ha Park; Manho Kim
Journal:  Headache       Date:  2005-09       Impact factor: 5.887

9.  Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults.

Authors:  N Breslau; G C Davis
Journal:  J Psychiatr Res       Date:  1993 Apr-Jun       Impact factor: 4.791

Review 10.  Serotonin and migraine: biology and clinical implications.

Authors:  E Hamel
Journal:  Cephalalgia       Date:  2007-11       Impact factor: 6.292

View more
  13 in total

1.  Treatment of migraine and the role of psychiatric medications.

Authors:  Elisa Cascade; Amir H Kalali; Todd A Smitherman
Journal:  Psychiatry (Edgmont)       Date:  2008-10

Review 2.  Migraine and depression: common pathogenetic and therapeutic ground?

Authors:  F Moschiano; D D'Amico; I Canavero; I Pan; G Micieli; G Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 3.  Headache secondary to psychiatric disorders.

Authors:  Todd A Smitherman; Steven M Baskin
Journal:  Curr Pain Headache Rep       Date:  2008-08

Review 4.  Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications.

Authors:  S M Baskin; Todd A Smitherman
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 5.  Psychiatric comorbidities of episodic and chronic migraine.

Authors:  Dawn C Buse; Stephen D Silberstein; Aubrey N Manack; Spyros Papapetropoulos; Richard B Lipton
Journal:  J Neurol       Date:  2012-11-07       Impact factor: 4.849

6.  The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.

Authors:  Ching-I Hung; Chia-Yih Liu; Ching-Hui Yang; Shuu-Jiun Wang
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

7.  Comorbidities of psychiatric and headache disorders in Nepal: implications from a nationwide population-based study.

Authors:  Ajay Risal; Kedar Manandhar; Are Holen; Timothy J Steiner; Mattias Linde
Journal:  J Headache Pain       Date:  2016-04-22       Impact factor: 7.277

8.  Migraine predicts physical and pain symptoms among psychiatric outpatients.

Authors:  Ching-I Hung; Chia-Yih Liu; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2013-02-27       Impact factor: 7.277

9.  Combination of anxiety and depression is associated with an increased headache frequency in migraineurs: a population-based study.

Authors:  Kyungmi Oh; Soo-Jin Cho; Yun Kyung Chung; Jae-Moon Kim; Min Kyung Chu
Journal:  BMC Neurol       Date:  2014-12-14       Impact factor: 2.474

10.  Associations of specific phobia and its subtypes with physical diseases: an adult community study.

Authors:  Cornelia Witthauer; Vladeta Ajdacic-Gross; Andrea Hans Meyer; Peter Vollenweider; Gerard Waeber; Martin Preisig; Roselind Lieb
Journal:  BMC Psychiatry       Date:  2016-05-21       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.